| 1 |
Younossi Z, Tacke F, Arrese M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [J]. Hepatology, 2019, 69(6): 2672-2682.
|
| 2 |
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases [J]. Hepatology, 2018, 67(1): 328-357.
|
| 3 |
de Lédinghen V, Wong GL, Vergniol J, et al. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease [J]. J Gastroenterol Hepatol, 2016, 31(4): 848-855.
|
| 4 |
Younossi Z, Stepanova M, Ong JP, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates [J]. Clin Gastroenterol Hepatol, 2019, 17(4): 748-755. e743.
|
| 5 |
Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis [J]. Lancet Gastroenterol Hepatol, 2019, 4(5): 389-398.
|
| 6 |
Leoni S, Tovoli F, Napoli L, et al. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis [J]. World J Gastroenterol, 2018, 24(30): 3361-3373.
|
| 7 |
Ballestri S, Romagnoli D, Nascimbeni F, et al. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications [J]. Expert Rev Gastroenterol Hepatol, 2015, 9(5): 603-627.
|
| 8 |
Wong VW, Chan WK, Chitturi S, et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: definition, risk factors and assessment [J]. J Gastroenterol Hepatol, 2018, 33(1): 70-85.
|
| 9 |
Ballestri S, Nascimbeni F, Baldelli E, et al. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases [J]. Metabolism, 2017, 72: 57-65.
|
| 10 |
Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation [J]. Am J Gastroenterol, 2007, 102(12): 2708-2715.
|
| 11 |
Bril F, Ortiz-Lopez C, Lomonaco R, et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients [J]. Liver Int, 2015, 35(9): 2139-2146.
|
| 12 |
Kim M, Kang BK, Jun DW. Comparison of conventional sonographic signs and magnetic resonance imaging proton density fat fraction for assessment of hepatic steatosis [J]. Sci Rep, 2018, 8(1): 7759.
|
| 13 |
Ballestri S, Nascimbeni F, Lugari S, et al. A critical appraisal of the use of ultrasound in hepatic steatosis [J]. Expert Rev Gastroenterol Hepatol, 2019, 13(7): 667-681.
|
| 14 |
Myers RP, Pollett A, Kirsch R, et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography [J]. Liver Int, 2012, 32(6): 902-910.
|
| 15 |
Berzigotti A, Ferraioli G, Bota S, et al. Novel ultrasound-based methods to assess liver disease: The game has just begun [J]. Dig Liver Dis, 2018, 50(2): 107-112.
|
| 16 |
Zhang X, Wong GL, Wong VW. Application of transient elastography in nonalcoholic fatty liver disease [J]. Clin Mol Hepatol, 2020, 26(2): 128-141.
|
| 17 |
Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis [J]. J Hepatol, 2017, 66(5): 1022-1030.
|
| 18 |
Kwok R, Choi KC, Wong GL, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study [J]. Gut, 2016, 65(8): 1359-1368.
|
| 19 |
Shi KQ, Tang JZ, Zhu XL, et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy [J]. J Gastroenterol Hepatol, 2014, 29(6): 1149-1158.
|
| 20 |
Imbault M, Faccinetto A, Osmanski BF, et al. Robust sound speed estimation for ultrasound-based hepatic steatosis assessment [J]. Phys Med Biol, 2017, 62(9): 3582-3598.
|
| 21 |
Dioguardi Burgio M, Imbault M, Ronot M, et al. Ultrasonic adaptive sound speed estimation for the diagnosis and quantification of hepatic steatosis: a pilot study [J]. Ultraschall Med, 2019, 40(6): 722-733.
|
| 22 |
Lin SC, Heba E, Wolfson T, et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique [J]. Clin Gastroenterol Hepatol, 2015, 13(7): 1337-1345. e1336.
|
| 23 |
Paige JS, Bernstein GS, Heba E, et al. A pilot comparative study of quantitative ultrasound, conventional ultrasound, and mri for predicting histology-determined steatosis grade in adult nonalcoholic fatty liver disease [J]. AJR Am J Roentgenol, 2017, 208(5): W168-W177.
|
| 24 |
Fujiwara Y, Kuroda H, Abe T, et al. The B-mode image-guided ultrasound attenuation parameter accurately detects hepatic steatosis in chronic liver disease [J]. Ultrasound Med Biol, 2018, 44(11): 2223-2232.
|
| 25 |
Webb M, Yeshua H, Zelber-Sagi S, et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis [J]. AJR Am J Roentgenol, 2009, 192(4): 909-914.
|
| 26 |
Martín-Rodríguez JL, Arrebola JP, Jiménez-Moleón JJ, et al. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy [J]. Eur J Gastroenterol Hepatol, 2014, 26(1): 88-94.
|
| 27 |
Xia MF, Yan HM, He WY, et al. Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method [J]. Obesity (Silver Spring), 2012, 20(2): 444-452.
|
| 28 |
Zhang B, Ding F, Chen T, et al. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content [J]. World J Gastroenterol, 2014, 20(47): 17985-17992.
|
| 29 |
Di Lascio N, Avigo C, Salvati A, et al. Steato-score: non-invasive quantitative assessment of liver fat by ultrasound imaging [J]. Ultrasound Med Biol, 2018, 44(8): 1585-1596.
|
| 30 |
Karlas T, Berger J, Garnov N, et al. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques [J]. World J Gastroenterol, 2015, 21(16): 4894-4902.
|
| 31 |
Son JY, Lee JY, Yi NJ, et al. Hepatic steatosis: assessment with acoustic structure quantification of US imaging [J]. Radiology, 2016, 278(1): 257-264.
|
| 32 |
Ballestri S, Lonardo A, Romagnoli D, et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD [J]. Liver Int, 2012, 32(8): 1242-1252.
|
| 33 |
Liu HK, Yang MC, Su YT, et al. Novel Ultrasonographic fatty liver indicator can predict hepatitis in children with non-alcoholic fatty liver disease [J]. Front Pediatr, 2018, 6: 416.
|
| 34 |
Ajmera V, Loomba R. Can elastography differentiate isolated fatty liver from nonalcoholic steatohepatitis? [J]. Semin Liver Dis, 2018, 38(1): 14-20.
|
| 35 |
Siddiqui MS, Vuppalanchi R, Van Natta ML, et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease [J]. Clin Gastroenterol Hepatol, 2019, 17(1): 156-163. e152.
|
| 36 |
Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis [J]. Gut, 2020, 69(7): 1343-1352.
|
| 37 |
林森浩, 丁红. 超声弹性成像评价肝脏硬度的研究进展 [J]. 中华肝胆外科杂志, 2012, 18(2): 158-160.
|
| 38 |
Ferraioli G, Wong VW, Castera L, et al. Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations [J]. Ultrasound Med Biol, 2018, 44(12): 2419-2440.
|
| 39 |
Mikolasevic I, Orlic L, Franjic N, et al. Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? [J]. World J Gastroenterol, 2016, 22(32): 7236-7251.
|
| 40 |
Petta S, Wong VW, Cammà C, et al. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values [J]. Hepatology, 2017, 65(4): 1145-1155.
|
| 41 |
罗文萍, 马红, 王宇. 瞬时弹性成像在肝纤维化无创诊断中的应用进展 [J]. 临床肝胆病杂志, 2018, 35(3): 635-639.
|
| 42 |
Kwok R, Tse YK, Wong GL, et al. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments [J]. Aliment Pharmacol Ther, 2014, 39(3): 254-269.
|
| 43 |
Wong GL, Wong VW, Chim AM, et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population [J]. J Gastroenterol Hepatol, 2011, 26(2): 300-305.
|
| 44 |
Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease [J]. Am J Gastroenterol, 2012, 107(12): 1862-1871.
|
| 45 |
de Lédinghen V, Wong VW, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan® [J]. J Hepatol, 2012, 56(4): 833-839.
|
| 46 |
Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients [J]. Hepatology, 2012, 55(1): 199-208.
|
| 47 |
Liu H, Fu J, Hong R, et al. Acoustic radiation force impulse elastography for the non-invasive evaluation of hepatic fibrosis in non-alcoholic fatty liver disease patients: a systematic review & meta-analysis [J]. PLoS One, 2015, 10(7): e0127782.
|
| 48 |
郑剑, 曾婕, 郑荣琴, 等. 二维剪切波弹性成像、瞬时弹性成像、实时组织弹性成像诊断肝纤维化的效能比较 [J/CD]. 中华医学超声杂志(电子版), 2016, 13(7): 496-500.
|
| 49 |
Herrmann E, de Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis [J]. Hepatology, 2018, 67(1): 260-272.
|
| 50 |
Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis [J]. Hepatology, 2017, 66(5): 1486-1501.
|
| 51 |
Cassinotto C, Boursier J, de Lédinghen V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy [J]. Hepatology, 2016, 63(6): 1817-1827.
|